CINECA IRIS Institutional Research Information System

DOGLIOTTI, Luigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.004
EU - Europa 5.447
AS - Asia 2.424
AF - Africa 51
OC - Oceania 36
SA - Sud America 26
Continente sconosciuto - Info sul continente non disponibili 5
Totale 13.993
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.787
CN - Cina 1.681
SE - Svezia 836
IE - Irlanda 731
DE - Germania 709
UA - Ucraina 683
FR - Francia 588
IT - Italia 562
FI - Finlandia 473
KR - Corea 431
GB - Regno Unito 389
CA - Canada 207
PL - Polonia 180
AT - Austria 137
VN - Vietnam 120
IN - India 48
DK - Danimarca 42
AU - Australia 33
BE - Belgio 29
JP - Giappone 29
NL - Olanda 29
SN - Senegal 25
TW - Taiwan 23
SG - Singapore 21
EG - Egitto 15
TR - Turchia 14
RU - Federazione Russa 13
BR - Brasile 12
HK - Hong Kong 11
IR - Iran 11
MX - Messico 9
TH - Thailandia 8
CH - Svizzera 6
CZ - Repubblica Ceca 6
PK - Pakistan 6
CL - Cile 5
ES - Italia 5
LB - Libano 5
MU - Mauritius 5
NO - Norvegia 5
PH - Filippine 5
ZA - Sudafrica 5
BG - Bulgaria 4
EU - Europa 4
PE - Perù 4
AR - Argentina 3
GR - Grecia 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
RS - Serbia 3
EC - Ecuador 2
HR - Croazia 2
ID - Indonesia 2
JO - Giordania 2
MM - Myanmar 2
PT - Portogallo 2
RO - Romania 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BY - Bielorussia 1
CU - Cuba 1
CY - Cipro 1
DZ - Algeria 1
LT - Lituania 1
LV - Lettonia 1
SI - Slovenia 1
Totale 13.993
Salva come PNG Salva come JPEG
Città #
Beijing 1.307
Chandler 809
Dublin 687
Houston 610
Ann Arbor 444
Jacksonville 396
Villeurbanne 376
Princeton 258
Medford 239
Dearborn 175
Warsaw 174
Fairfield 159
Nyköping 142
Milan 140
Wilmington 140
Vienna 135
Ashburn 133
Toronto 132
Hangzhou 119
Boston 117
Woodbridge 96
Fremont 90
Verona 84
Redwood City 67
Dong Ket 61
Boardman 59
Seattle 55
Lachine 51
Cambridge 45
Pisa 44
Torino 43
Norwalk 38
Falls Church 36
Hefei 30
Menlo Park 26
Guangzhou 25
Shanghai 21
Redmond 20
Munich 19
Brussels 18
Kunming 18
Jinan 17
Mountain View 17
Detroit 15
Nanjing 15
Shenyang 15
Tokyo 15
New York 14
San Diego 14
Taipei 14
Auburn Hills 13
Chicago 12
Chengdu 11
Düsseldorf 11
Monash 11
Hanoi 10
Phoenix 10
Pune 10
Washington 10
Zhengzhou 10
Bologna 9
Turin 9
Columbus 8
Helsinki 8
Philadelphia 8
Nanchang 7
Nürnberg 7
Seoul 7
Spokane 7
Austin 6
Fuzhou 6
Istanbul 6
Rome 6
Sydney 6
Brescia 5
Cairo 5
Hebei 5
Los Angeles 5
Shenzhen 5
Taizhou 5
Arese 4
Bari 4
Bottanuco 4
Campobasso 4
Des Moines 4
Genoa 4
Gent 4
Guadalupe 4
Hyderabad 4
London 4
Naples 4
Paris 4
Rivoli 4
Rotterdam 4
Taormina 4
Tappahannock 4
Vancouver 4
Varese 4
Bangalore 3
Bangkok 3
Totale 8.090
Salva come PNG Salva come JPEG
Nome #
Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients 528
Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy. 374
Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease 214
Pharmacoeconomic comparison between chronochemotherapy and FOLFOX regimen in the treatment of patients with metastatic colorectal cancer: a cost-minimization study 172
Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimen 170
Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis 166
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study. 160
Bevacizumab Plus Octreotide and Metronomic Capecitabine in Patients with Metastatic Well-to-Moderately Differentiated Neuroendocrine Tumors. The XELBEVOCT Multicenter Phase II Study 154
[Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline] 149
Thyroid hormone levels in human breast cyst fluid. 143
CIRCADIAN RHYTHM OF BONE TURNOVER MARKERS INBREAST CANCER PATIENTS WITH METASTATIC BONE DISEASE ANDIN CONTROL SUBJECTS 140
Three-year findings of an early lung cancer detection feasibility study with low-dose spiral computed tomography in heavy smokers 140
Prevalence of complementary/alternative medicines (CAMs) in a cancer population in northern Italy receiving antineoplastic treatments and relationship with quality of life and psychometric features. 134
Adenohypophyseal hormone levels in the cerebrospinal fluid of patients with pituitary disease. 123
Prolactin and thyrotropin response to thyrotropin-releasing hormone in premenopausal women with fibrocystic disease of the breast. 119
International expert consensus on primary systemic therapy in the management of early breast cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013) 119
Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases. 118
THE ROLE OF HEMOGLOBIN LEVEL IN PREDICTING THE RESPONSE TO FIRST-LINE CHEMOTHERAPY IN ADVANCED COLORECTAL CANCER (ACC) PATIENTS 117
Stage IB malignant thymoma in a Lynch syndrome patient with multiple cancers: response to incidental administration of oxaliplatin and 5-fluorouracil 113
Cations and dehydroepiandrosterone-sulfate in cyst fluid of pre- and menopausal patients with gross cystic disease of the breast. Evidence for the existence of subpopulations of cysts. 111
Confronto tra due metodi per la misura della concentrazione della cromogranina A circolante in pazienti con iperplasia prostatica benigna e adenocarcinoma prostatico 103
Diagnostica per immagini 99
Chromogranine A serum levels in patients affected by prostate cancer and benign prostate hypertrophy: comparison between two different commercial kits 99
A randomized comparison of high dose epirubicin versus high dose epirubicin plus lonidamine in advanced breast cancer patients. First results from a cooperative group study 95
Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma. 93
Apocrine cells in breast cyst fluid and their relationship to cyst type: a morphometric study. 93
Case-control study of the impact of adjuvant hormone therapy in prostate cancer patients on quality of life, anxiety and depression and self body image perception 93
Circadian rhythm of breakthrough cancer pain. 92
[Cytostatic therapy of metastatic breast cancer] 91
Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial. 91
Melatonin and human cancer. 90
Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer 90
Cronochemioterapia dei tumori del colon-retto avanzati 89
Current status of hormonal therapy of fibrocystic breast disease. 88
Distúrbio Pós-Traumático de Stress, qualidade do sono, ansiedade, depressão e qualidade de vida em pacientes oncológicos em tratamento quimioterápico 84
Acute myeloblastic leukemia associated with mediastinal nonseminomatous germ cell tumors. Report on two cases. 83
Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approach. 83
Comparison between two commercially available chromogranin A assays in detecting neuroendocrine differentiation in prostate cancer and benign prostate hyperplasia 81
The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients 81
The transition from pediatrics to adult medicine in patients recovered after an infantile neoplasm 80
Aggiornamenti in Cronochemioterapia 79
Prevention of nausea and vomiting in cisplatin-treated patients by a selective 5-hydroxytryptamine (5-HT3) receptor antagonist, ICS 205-930. 78
Shifted distribution of cation-related cyst types in post-menopausal patients with gross cystic disease of the breast. 78
Biochemical picture of bone metabolism in breast cancer patients with bone metastases. 78
Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy 76
Bisogni di cure palliative: i problemi dei pazienti con tumore nei loro ultimi mesi di vita. Un asurvey in 6 ASL piemontesi 75
Potential clinical value of circulating chromogranin A in patients with prostate carcinoma. 75
Differences between temporal patterns of plasma cortisol and corticosteroid-binding globulin binding capacity throughtout the twenty-four hour day and the menstrual cycle. 74
Cohort study of association of risk of breast cancer with cyst type in women with gross cystic disease of the breast. 74
Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension. 74
[Study of the distribution and metabolism of T4-I 125 and of T3-I 125 in the rat] 73
Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease. 73
Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma 73
[Acute effect of ACTH administered in vivo on the 11-beta-hydroxylase activity of rat adrenal gland homogenates] 72
[On the pituitary-inhibiting action and pharmacokinetics of some synthetic corticosteroids] 72
Background to and management of treatment-related bone loss in prostate cancer. 70
Changes in body composition after androgen deprivation therapy (ADT) in prostate cancer patients. Relationship with disease outcome 70
[Effect of 17-beta-estradiol on inhibition of corticosteroidogenesis obtained with metopirone] 69
[Rapid determination of total estrogens in pregnancy. Possibilities and limitations of the method] 69
Influence of neoadjuvant chemotherapy on serum tumor markers CA 15-3, MCA, CEA, TPS and TPA in breast cancer patients with operable disease. 68
The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor load. 68
Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a. A study by the Italian Trials in Medical Oncology Group. 67
Biochemistry of breast cyst fluid. An approach to understanding intercellular communication in the terminal duct lobular units. 67
THE ONSET OF SKELETAL COMPLICATIONS IN HORMONEREFRACTORY PROSTATE CANCER PATIENTS IS NOT INFLUENCEDBY THE DURATION OF ANDROGEN DEPRIVATION THERAPY 67
[Regional hemodynamics in the rat: changes induced by administration of adrenaline and of a beta-blocking drug (INPEA)] 67
Chemotherapy with dacarbazine and 5-fluorouracil in advanced medullary thyroid cancer. 66
Risk of depressive events in long-term surviving patients affected by hormone-related cancer according to time after diagnosis 66
Cytotoxic chemotherapy for adrenocortical carcinoma. 66
A new magnesium-containing PEG-electrolyte solution for the oral lavage of the colon. 65
A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma. International Organization for Cancer Chronotherapy. 65
Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapy 65
Independent factors predict supranormal CA 15-3 serum levels in advanced breast cancer patients at first disease relapse. 65
Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast. 64
Advanced prostate cancer: at last a role for medical oncologists 63
[Comparison between regional hemodynamics in the rat during barbiturate anesthesia and during ether anesthesia] 62
Somatostatin receptors: from basic science to clinical approach. Unlabeled somatostatin analogues-1: Prostate cancer 62
INCREASED NUMBER OF NEUROENDOCRINE CELLS IN METASTATIC COLORECTAL ADENOCARCINOMA FOLLOWING CHEMO/RADIOTHERAPY 62
The role of hemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer (ACC) 62
[Endocrine therapy in breast carcinoma] 61
Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer 61
[Influence of a beta-blocking drug on the clearance time of thyroxine-I-125 from plasma in rats] 61
Six-year stabilisation of a relapsed pelvic mass from rectal cancer after oxaliplatin-containing chemotherapy 61
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly 61
Emerging drugs for adrenocortical carcinoma 61
Durable complete remission after weekly docetaxel administration in a patient with mediastinal non-seminomatous germ-cell tumor refractory to cisplatin-based chemotherapy 61
Circadian rhythm of bone turnover markers in breast cancer patients with bone metastases and in control subjects 61
[Influence of adrenaline and a beta-blocking drug on distribution of thyroxine] 61
[Preliminary observations on the influence of thyroxine on the 11-beta-hydroxylase activity of homogenized extracts of rat adrenal glands in vitro] 60
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC). 60
Laparoscopic treatment of Morgagni-Larrey hernia: technical details and report of a series 59
Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients. 59
[Therapeutic use of corticosteroids] 59
The neuroendocrine phenotype in prostate cancer: basic and clinical aspects 59
Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer 59
Low-dose spiral CT for early diagnosis of lung cancer in a light risk population: 2-year results 59
Osteoblastic flare assessed by serum alkaline phosphatase activity is an index of short duration of response in prostate cancer patients with bone metastases submitted to systemic therapy.Gruppo Onco Urologico Piemontese (G.O.U.P). 58
Il trattamento dell'ascite neoplastica: obiettivi e criteri di valutazione 58
Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review. 58
Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer. 57
The endocrine basis of benign breast disorders. 57
Totale 9.212
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.054
article - articoli 0
book - libri 0
conference - conferenze 3.722
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.776
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019419 0 0 0 0 0 0 0 0 0 74 264 81
2019/20202.272 62 82 183 201 233 475 320 139 223 130 153 71
2020/20211.535 177 44 188 80 133 63 175 29 233 142 75 196
2021/20221.965 27 67 70 316 122 59 233 79 53 84 306 549
2022/20232.481 334 178 43 215 224 735 213 139 239 23 84 54
2023/2024637 136 183 61 56 31 67 7 35 13 48 0 0
Totale 14.567